Bavarian Nordic's partner Eurofarma has submitted an application to Brazil's health authority Anvisa for approval of the chikungunya vaccine CHIKV VLP, targeting prevention in people aged 12 and above. This marks a key step in making the vaccine available in Brazil, a country heavily affected by chikungunya, which causes severe joint pain and chronic arthritis in many cases. The vaccine, already approved in the US, Europe, UK, Switzerland, and Canada, is a single-dose, non-infectious vaccine designed to quickly trigger immunity. Eurofarma will handle regulatory, commercialization, and distribution activities in Brazil, while Bavarian Nordic remains the producer. The approval process is expected to advance efforts to control chikungunya's spread and impact in the region.
The Software Defined Vehicle (SDV) market is projected to expand from USD 447.55 billion in 2026 to USD 1,707.36 billion by 2035, growing at a compound annual growth rate (CAGR) of 16.0%. This growth is driven by the automotive industry's shift towar...
Popsicle has launched a summer-long Flavor Feud, separating its Cherry, Orange, and Grape ice pop flavors into competing teams led by celebrity captains. Fans are invited to choose their favorite flavor by purchasing solo packs and supporting their t...
Bonaventure has started construction on Attain at Newtown, a $85.3 million, 320-unit Class A multifamily development in Norfolk, Virginia, located in a federally designated Qualified Opportunity Zone. The project, financed through a partnership with ...
Egoist Machines, backed by Y Combinator, has launched AI Passport, a secure system allowing users to store and manage their personal data and preferences across various AI assistants like ChatGPT and Claude. This tool addresses concerns about data pr...
Bavarian Nordic's partner Eurofarma has submitted a regulatory approval application for the chikungunya vaccine CHIKV VLP to Brazil's health agency Anvisa. This marks a key step in making the vaccine available in Brazil, which reports over half of gl...
